Should I Increase HCG for Fertility? (TRT Q&As)
Timeline
Timestamp
Topic
09:00
Should I increase my HCG dose to improve my sperm count and fertility?
The member says HCG has maintained testosterone around 400 and increased his sperm count above 15 million, but his fertility urologist recommends increasing from 1,000 to 1,500 IU three times weekly. Dr. O’Connor discusses using the lowest effective HCG dose, the member’s underlying secondary hypogonadism, and the need to optimize fertility rather than focusing primarily on testosterone levels.
The member says HCG has maintained testosterone around 400 and increased his sperm count above 15 million, but his fertility urologist recommends increasing from 1,000 to 1,500 IU three times weekly. Dr. O’Connor discusses using the lowest effective HCG dose, the member’s underlying secondary hypogonadism, and the need to optimize fertility rather than focusing primarily on testosterone levels.
32:10
Could letrozole worsen my cholesterol and cardiovascular risk?
The member is concerned about starting letrozole because he already has a positive coronary calcium score and wants to keep LDL as low as possible. Dr. O’Connor agrees that aggressive estrogen suppression can adversely affect lipids and questions using letrozole routinely in this fertility setting.
The member is concerned about starting letrozole because he already has a positive coronary calcium score and wants to keep LDL as low as possible. Dr. O’Connor agrees that aggressive estrogen suppression can adversely affect lipids and questions using letrozole routinely in this fertility setting.
36:00
Would enclomiphene be better than clomiphene for improving fertility?
Dr. O’Connor explains that there is not strong evidence proving enclomiphene is superior for fertility, although its more selective isomer may allow a lower dose. He discusses it as a possible option alongside HCG while emphasizing that the goal is improving spermatogenesis rather than chasing testosterone numbers.
Dr. O’Connor explains that there is not strong evidence proving enclomiphene is superior for fertility, although its more selective isomer may allow a lower dose. He discusses it as a possible option alongside HCG while emphasizing that the goal is improving spermatogenesis rather than chasing testosterone numbers.
46:10
Is there a predictable point when HCG stops working because of LH receptor downregulation?
Dr. O’Connor says there is no predictable timeline because the response varies from man to man. He explains that HCG can help maintain testicular function and fertility, but prolonged stimulation may become less effective in some men and treatment needs to be individualized.
Dr. O’Connor says there is no predictable timeline because the response varies from man to man. He explains that HCG can help maintain testicular function and fertility, but prolonged stimulation may become less effective in some men and treatment needs to be individualized.
60:30
Should I increase my TRT dose if my motivation and drive still do not feel fully restored?
The member has been on TRT for nearly two months and feels substantially better but says his drive is still not where he wants it to be. Dr. O’Connor recommends finding the lowest effective testosterone dose, allowing adequate time to assess the response, and judging treatment by symptoms together with the ABCDs™ rather than simply increasing testosterone to chase a number.
The member has been on TRT for nearly two months and feels substantially better but says his drive is still not where he wants it to be. Dr. O’Connor recommends finding the lowest effective testosterone dose, allowing adequate time to assess the response, and judging treatment by symptoms together with the ABCDs™ rather than simply increasing testosterone to chase a number.
72:40
What is the best injection site for TRT: the thigh, deltoid, or glute?
Dr. O’Connor discusses his experience with deltoid, lateral thigh, and gluteal injections and explains that men can rotate among appropriate sites based on comfort and accessibility. He also discusses smaller-gauge needles and emphasizes finding a sustainable injection technique that minimizes discomfort and repeated trauma.
Dr. O’Connor discusses his experience with deltoid, lateral thigh, and gluteal injections and explains that men can rotate among appropriate sites based on comfort and accessibility. He also discusses smaller-gauge needles and emphasizes finding a sustainable injection technique that minimizes discomfort and repeated trauma.
Video Summary
This session addresses a range of questions that come up in real-world hormone and metabolic care. Rather than treating any single number as definitive, the discussion emphasizes decision-making that integrates symptoms, history, and repeatable trends. Viewers get a clear sense of how clinicians prioritize stability and follow-up when uncertainty is high.
Several segments focus on how and when to adjust a plan, including dosing choices, monitoring cadence, and symptom tracking. The conversation highlights common misinterpretations that lead to unnecessary changes, and it explains what would justify reassessment. Practical framing is provided so patients can bring better questions to follow-up visits.
Risk and prevention themes also appear throughout, including cardiometabolic markers and long-term health planning. The session reinforces that individualized care depends on context, goals, and tolerability, not rigid rules. Overall, the episode provides a structured way to think about next steps without losing sight of long-term outcomes.
Drug Callouts
Drug
Description
Testosterone
Testosterone is an androgen hormone that supports sexual function, red blood cell production, bone density, and muscle mass. The Q&A touches on testosterone in the context of monitoring goals, symptom reports, and risk tradeoffs discussed during the session.
Semaglutide
Semaglutide is a GLP‑1 receptor agonist used for type 2 diabetes and weight management that enhances glucose-dependent insulin secretion and slows gastric emptying. The session connects semaglutide to clinical decision points such as reassessment intervals, expected response, and avoiding overreaction to isolated changes.
Condition Callouts
Condition
Description
Diabetes
Diabetes mellitus is a metabolic disorder characterized by chronic hyperglycemia due to impaired insulin secretion, insulin action, or both. The Q&A touches on diabetes in the context of monitoring goals, symptom reports, and risk tradeoffs discussed during the session.
Sleep Apnea
Obstructive sleep apnea is recurrent upper-airway obstruction during sleep causing intermittent hypoxia and fragmented sleep. The conversation references sleep apnea while weighing practical next steps, follow-up timing, and what would trigger reconsideration.
Key Takeaways
- Dose changes should be trend-driven and anchored to symptom patterns rather than isolated results.
- Administration consistency reduces variability and supports clearer interpretation of response.
- Monitoring works best when it is matched to specific clinical decisions and safety thresholds.
- Symptoms can lag behind lab changes, so timelines should be set realistically.
- Long-term follow-up structure prevents overreaction and improves outcomes.